FR2118012B1 - - Google Patents

Info

Publication number
FR2118012B1
FR2118012B1 FR7144419A FR7144419A FR2118012B1 FR 2118012 B1 FR2118012 B1 FR 2118012B1 FR 7144419 A FR7144419 A FR 7144419A FR 7144419 A FR7144419 A FR 7144419A FR 2118012 B1 FR2118012 B1 FR 2118012B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7144419A
Other languages
French (fr)
Other versions
FR2118012A1 (cg-RX-API-DMAC7.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline & French Laboratories Ltd
GlaxoSmithKline LLC
Original Assignee
Smith Kline & French Laboratories Ltd
GlaxoSmithKline LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline & French Laboratories Ltd, GlaxoSmithKline LLC filed Critical Smith Kline & French Laboratories Ltd
Publication of FR2118012A1 publication Critical patent/FR2118012A1/fr
Application granted granted Critical
Publication of FR2118012B1 publication Critical patent/FR2118012B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/12—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/125—1,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR7144419A 1970-12-17 1971-12-10 Expired FR2118012B1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US9929670A 1970-12-17 1970-12-17
US11659871A 1971-02-18 1971-02-18
US11659971A 1971-02-18 1971-02-18
US12540371A 1971-03-17 1971-03-17

Publications (2)

Publication Number Publication Date
FR2118012A1 FR2118012A1 (cg-RX-API-DMAC7.html) 1972-07-28
FR2118012B1 true FR2118012B1 (cg-RX-API-DMAC7.html) 1975-10-31

Family

ID=27493051

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7144419A Expired FR2118012B1 (cg-RX-API-DMAC7.html) 1970-12-17 1971-12-10

Country Status (17)

Country Link
AR (1) AR194216A1 (cg-RX-API-DMAC7.html)
AU (1) AU459002B2 (cg-RX-API-DMAC7.html)
BE (1) BE776222A (cg-RX-API-DMAC7.html)
BR (1) BR7108309D0 (cg-RX-API-DMAC7.html)
CA (1) CA990281A (cg-RX-API-DMAC7.html)
CH (1) CH578581A5 (cg-RX-API-DMAC7.html)
DD (1) DD94997A5 (cg-RX-API-DMAC7.html)
DE (1) DE2162575A1 (cg-RX-API-DMAC7.html)
FR (1) FR2118012B1 (cg-RX-API-DMAC7.html)
GB (1) GB1328340A (cg-RX-API-DMAC7.html)
HU (1) HU166307B (cg-RX-API-DMAC7.html)
IE (1) IE35875B1 (cg-RX-API-DMAC7.html)
IL (1) IL38099A (cg-RX-API-DMAC7.html)
IT (1) IT1061965B (cg-RX-API-DMAC7.html)
NL (1) NL7116791A (cg-RX-API-DMAC7.html)
PH (1) PH9531A (cg-RX-API-DMAC7.html)
RO (1) RO59318A (cg-RX-API-DMAC7.html)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1022544A (en) * 1972-12-21 1977-12-13 Yukiyasu Murakami Process of preparing a heterocyclic acyl group-substituted cephalosporin derivative
KR780000197B1 (en) * 1972-12-26 1978-05-26 Bristol Myers Co Method for preparing antibacterial agent
PH16419A (en) * 1973-01-31 1983-09-29 Bristol Myers Co 7-(d-alpha-amino-alpha-(3'-methyl-4'-hydroxyphenyl)-acetamido)-3-(1,2,3-triazol-5-ylthiomethyl)-3-cephem-4-carboxylic acid,pharmaceutically acceptable esters and salts thereof
JPS5732074B2 (cg-RX-API-DMAC7.html) * 1974-01-30 1982-07-08
JPS5732075B2 (cg-RX-API-DMAC7.html) * 1974-02-20 1982-07-08
AR205537A1 (es) * 1973-05-10 1976-05-14 Fujisawa Pharmaceutical Co Procedimiento para la preparacion de derivados de acido 7-substituido fenilglicinamido - 3 - substituido - 3 - cefem - 4 - carboxilicos
CA1030523A (en) * 1973-06-25 1978-05-02 Taiiti Okada Cephalosporins
US3936446A (en) * 1974-02-19 1976-02-03 Beecham Group Limited Isocyanocephalosporanates
JPS5729475B2 (cg-RX-API-DMAC7.html) * 1974-04-11 1982-06-23
US4178445A (en) 1974-03-28 1979-12-11 Fujisawa Pharmaceutical Co., Ltd. 7-(α-Substituted glycinamido)-3-substituted methyl-3-cephem-4-carboxylic acids and their derivatives
GB1476981A (en) * 1974-06-05 1977-06-16 Bristol Myers Co Substituted penicillanic acids
IL48090A0 (en) * 1974-09-19 1975-11-25 Merck Patent Gmbh Cephem derivatives,their preparation and compositions containing them
US3994877A (en) * 1975-07-22 1976-11-30 Richardson-Merrell Inc. 6-[α-AMINO-ω-(3,4-METHYLENEDIOXYPHENYL)ACYLAMIDO]PENICILLANIC ACID DERIVATIVES
US3994876A (en) * 1975-07-22 1976-11-30 Richardson-Merrell Inc. 6-[α-AMINO-ω-(2,3-METHYLENEDIOXYPHENYL)ACYLAMIDO]PENICILLANIC ACID DERIVATIVES
US4033956A (en) 1975-07-22 1977-07-05 Richardson-Merrell Inc. 7[α-Amino-ω-(2,3-methylenedioxy-phenyl)acylamido]cephalosporanic acid derivatives
GB1579532A (en) * 1976-05-21 1980-11-19 Farmaceutici Italia Cephalosporins
CH634848A5 (de) * 1976-08-17 1983-02-28 Fujisawa Pharmaceutical Co Verfahren zur herstellung neuer 7-(n-substituierter 2-phenylglycinamido)-3-substituierte-3-cephem-4-carbonsaeuren.
US4319028A (en) * 1976-08-26 1982-03-09 Eli Lilly And Company 7-(2-(Substituted benzoyl)amino)acetamido)cephalosporins
GR74995B (cg-RX-API-DMAC7.html) * 1980-08-27 1984-07-12 Ciba Geigy Ag
WO1984001949A1 (fr) * 1982-11-10 1984-05-24 Kyoto Pharma Ind Derives de cephalosporine, leur procede de preparation et agent prophylactique de traitement contre les infections bacteriennes
CN111187284A (zh) * 2020-03-10 2020-05-22 赵俊瑶 一种头孢克洛的制备方法

Also Published As

Publication number Publication date
IL38099A (en) 1976-01-30
NL7116791A (cg-RX-API-DMAC7.html) 1972-06-20
BE776222A (fr) 1972-06-05
DD94997A5 (cg-RX-API-DMAC7.html) 1973-01-12
GB1328340A (en) 1973-08-30
HU166307B (cg-RX-API-DMAC7.html) 1975-02-28
DE2162575A1 (de) 1972-07-27
CH578581A5 (cg-RX-API-DMAC7.html) 1976-08-13
IE35875L (en) 1972-06-17
FR2118012A1 (cg-RX-API-DMAC7.html) 1972-07-28
CA990281A (en) 1976-06-01
AR194216A1 (es) 1973-06-29
AU459002B2 (en) 1975-03-13
PH9531A (en) 1976-01-09
IE35875B1 (en) 1976-06-09
AU3682771A (en) 1973-06-14
BR7108309D0 (pt) 1973-07-03
RO59318A (ro) 1981-01-30
IT1061965B (it) 1983-04-30

Similar Documents

Publication Publication Date Title
FR2085775B1 (cg-RX-API-DMAC7.html)
FR2088255A1 (cg-RX-API-DMAC7.html)
FR2095307B1 (cg-RX-API-DMAC7.html)
FR2118012A1 (cg-RX-API-DMAC7.html)
FR2110029A5 (cg-RX-API-DMAC7.html)
FR2086481B1 (cg-RX-API-DMAC7.html)
FR2085843B1 (cg-RX-API-DMAC7.html)
FR2080762B1 (cg-RX-API-DMAC7.html)
FR2095313B1 (cg-RX-API-DMAC7.html)
FR2080826B1 (cg-RX-API-DMAC7.html)
FR2078772A5 (cg-RX-API-DMAC7.html)
FR2102161A1 (cg-RX-API-DMAC7.html)
FR2081593B1 (cg-RX-API-DMAC7.html)
FR2080665A1 (cg-RX-API-DMAC7.html)
FR2088764A5 (cg-RX-API-DMAC7.html)
FR2080779B1 (cg-RX-API-DMAC7.html)
FR2088554B1 (cg-RX-API-DMAC7.html)
FR2091108A5 (cg-RX-API-DMAC7.html)
FR2088747A5 (cg-RX-API-DMAC7.html)
FR2095263A1 (cg-RX-API-DMAC7.html)
FR2095339B1 (cg-RX-API-DMAC7.html)
FR2089272A5 (cg-RX-API-DMAC7.html)
FR2109981A5 (cg-RX-API-DMAC7.html)
FR2103394A1 (cg-RX-API-DMAC7.html)
FR2085743B1 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
ST Notification of lapse